{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/syphilis/background-information/prevalence/","result":{"pageContext":{"chapter":{"id":"6dd4a0d4-fa9a-593e-888e-9e2f53fd28f7","slug":"prevalence","fullItemName":"Prevalence","depth":2,"htmlHeader":"<!-- begin field 373f62ea-18b2-4816-8c84-7f52001c6c5b --><h2>How common is it?</h2><!-- end field 373f62ea-18b2-4816-8c84-7f52001c6c5b -->","summary":"","htmlStringContent":"<!-- begin item 3103f763-159a-4c4a-bf74-8f64a8892da8 --><!-- begin field d1076305-778d-40b2-889a-04bf1c224102 --><ul><li><strong>Globally </strong>— the World Health Organisation (WHO) estimated that globally in 2012 [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">WHO, 2016</a>]: <ul><li>In people aged 15–49 years of age:<ul><li>There were 5.6 million new cases of syphilis — an incidence rate of 1.5  per 1000 females and 1.5 per 1000 males.</li><li>There were 18 million prevalent cases of syphilis — a prevalence of 0.5% in females and 0.5% in males, with the highest prevalence in the WHO African Region.</li></ul></li><li>There were 930,000 maternal syphilis infections which resulted in 350,000 adverse pregnancy outcomes, including stillbirths, neonatal deaths, preterm births and infected infants.</li></ul></li><li><strong>Europe</strong> — European surveillance data has shown that syphilis notification rates are increasing (in particular among men who have sex with men [MSM]) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">ECDC, 2019</a>]. <ul><li>In 2017, the highest rates among men (per 100,000 population) were reported in Iceland (25), the United Kingdom (22), Malta (22), Germany (17) and Ireland (16).</li><li>In 2017, the highest rates among women (per 100,000 population) were reported in Iceland (6.0), Bulgaria (5.4), Latvia (4.8) and Lithuania (4.8).</li><li>Notification rates were consistently higher among men and increased from 6.8 to 12.1 per 100,000 population between 2007 and 2017.</li><li>Among women, rates decreased from 2.3 to 1.4 per 100,000 population between 2007 and 2017.</li></ul></li><li><strong>UK</strong> — the prevalence of syphilis in the UK has continued to increase in recent years.<ul><li>New diagnoses of syphilis in England rapidly increased between 2013 and 2018 from 3344 to 7541 [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2019</a>].<ul><li>Most of the new diagnoses (75%) in 2018 were in MSM and reflect outbreaks and clusters in London, Manchester and Brighton [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2019</a>].</li><li>In newly diagnosed cases (n=2969) of syphilis in MSM in London in 2017; around half (47%) were diagnosed with another new STI during the same episode or within the previous year; the median age was 37 years; 74% were white and 45% were born in the UK [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2018</a>]. </li></ul></li><li>Of MSM with syphilis around 40% have co-infection with HIV-1 [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">BASHH, 2019</a>]. </li><li>The number of diagnoses among heterosexuals rose from 775 to 1391 between 2013 and 2018 in England — an increase of 63% in males and 35% in females [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2019</a>]. </li></ul></li></ul><!-- end field d1076305-778d-40b2-889a-04bf1c224102 --><!-- end item 3103f763-159a-4c4a-bf74-8f64a8892da8 -->","topic":{"id":"e20bf9b2-b7e3-5fd7-8829-79eff4ba17c6","topicId":"acdacd5c-088e-4bc3-b3f7-ec4a5cdf69d3","topicName":"Syphilis","slug":"syphilis","lastRevised":"Last revised in December 2019","chapters":[{"id":"e937b36a-5802-56e1-8c33-d31a18aa8993","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8e1009a7-fe76-55c5-a3b4-71f4ab22bd6e","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"3744efb5-ed9a-556d-b9ca-9497279f7760","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"1a6d6164-e61e-5a2b-899c-b42fdd49c070","slug":"changes","fullItemName":"Changes"},{"id":"42b3bae7-13c9-5f24-8610-e6373d51db6c","slug":"update","fullItemName":"Update"}]},{"id":"783939a0-7dd0-51dc-b0f1-1a79adaeeca2","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"481c647b-0185-5ec1-944f-ea3f095a698e","slug":"goals","fullItemName":"Goals"},{"id":"5d1c604c-5520-5fd3-906b-277d5bc648e4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c1d0b67c-29a5-571e-a1e8-8037aa0cca4c","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7c0ed1af-9d86-5a85-a39d-bac1f3ee5aa6","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"b5682ffb-43d2-5180-b6ef-2442bbeddb7f","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"46feecc4-1ab5-56cc-88d4-0a134227de45","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"4bd10070-ee64-5280-b905-06b3eb114be4","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"d6720e54-e02c-58ce-b1a6-033c00e802a7","slug":"definition","fullItemName":"Definition"},{"id":"a0c2113e-ec1b-5779-a10a-478a338f5123","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"6dd4a0d4-fa9a-593e-888e-9e2f53fd28f7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b748bc0a-b4dd-5cd5-a38c-5a8565c1a29a","slug":"prognosis","fullItemName":"Prognosis"},{"id":"76255843-9dc0-5005-8f9d-8ad229263649","slug":"complications","fullItemName":"Complications"}]},{"id":"f6319d5a-f16e-52a4-85ba-52fc5bdf0dfd","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"bc588915-36d7-5368-b3b1-55539fe07a98","slug":"when-to-suspect-syphilis","fullItemName":"When to suspect syphilis"},{"id":"6c61a9cf-feda-52ea-b119-caf357efc7b1","slug":"assessment","fullItemName":"Assessment"},{"id":"ca12c8de-69c5-5487-9003-b91829ef1e03","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"eb1d937a-afbb-5c69-807a-d6560cf1f127","fullItemName":"Management","slug":"management","subChapters":[{"id":"4f71ffc0-f98f-5f3f-9752-9b49ae232b3f","slug":"management-of-suspected-syphilis","fullItemName":"Scenario: Management of suspected syphilis"}]},{"id":"94de066c-68d9-5f6d-93f5-8e51c88d0606","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ec180069-3dfc-52bb-8d33-474b29350978","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"5989431d-2289-5a0d-8965-3fb04b1df99d","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"9a2ece67-c769-5551-bfb8-806b9499e079","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"daa5da38-6a12-51e2-88c0-c16841f9c9d8","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"18097171-0d2a-50aa-bf36-707fb65c028c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"1ec2e8ce-2b99-5671-b5e5-14986c70f439","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"0656a654-b988-57ed-b218-fb52feabfa93","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4bd10070-ee64-5280-b905-06b3eb114be4","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}